SYROS PHARMACEUTICALS, INC. Long-Term Debt, Maturity, Year Four
SYROS PHARMACEUTICALS, INC. had Long-Term Debt, Maturity, Year Four of $2.86 million as of 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2024-10-31
- 2024-09-30: Long-Term Debt, Maturity, Year Four $2.86M.
- 2024-06-30: Long-Term Debt, Maturity, Year Four $2.86M.
- 2022-12-31: Long-Term Debt, Maturity, Year Four $3.33M.
- 2022-09-30: Long-Term Debt, Maturity, Year Four $5.00M.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2024-09-30 | $2.86M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $2.86M 10-Q · filed 2024-07-31 |
| 2022-12-31 | $3.33M 10-K · filed 2023-03-02 |
| 2022-09-30 | $5.00M 10-Q · filed 2022-11-14 |
| 2021-12-31 | $3.33M 10-K · filed 2022-03-15 |
| 2021-09-30 | $3.33M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $3.33M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $3.33M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $20.00M 10-K · filed 2021-03-04 |
| 2020-09-30 | $10.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $8.33M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $8.33M 10-Q · filed 2020-05-07 |